Atlas Trials

Intrathecal Autologous Adipose-derived Mesenchymal Stromal Cells for Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT03268603 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT03268603
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ALSAmyotrophic Lateral Sclerosis
Start date
2017-10-10
Primary completion
2024-01-31
Enrollment
75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.